聯(lián)系電話
上海起發(fā)實(shí)驗(yàn)試劑有限公司
中級會(huì)員·16年
- 聯(lián)系人：
- 楊經(jīng)理
- 電話：
- 021-50724187 021-50724961
- 手機(jī)：
- 15921799099
- 傳真：
- 021-50724961
- 地址：
- 上海浦東川沙鎮(zhèn)川沙路6619號上海起發(fā)實(shí)驗(yàn)試劑有限公司
- 個(gè)性化：
- www.qfbio.com
- 網(wǎng)址：
- www.qfbio.com
掃一掃訪問手機(jī)商鋪
 提 供 商 |
上海起發(fā)實(shí)驗(yàn)試劑有限公司 |  資料大小 |
546.1KB |
|---|---|---|---|
 資料類型 |
EXCEL 文檔 |  資料圖片 |
|
 下載次數(shù) |
1次 |  瀏覽次數(shù) |
96次 |
JPT 2025年價(jià)格表
JPT Peptide Technologies是一家總部位于德國的生物技術(shù)公司，擁有超過20年的肽研發(fā)與生產(chǎn)經(jīng)驗(yàn)，致力于為全球科研機(jī)構(gòu)、制藥企業(yè)及臨床研究提供高質(zhì)量的肽類產(chǎn)品與服務(wù)。作為ISO 9001:2015認(rèn)證企業(yè)，公司通過嚴(yán)格的年度審核體系，確保從研發(fā)到生產(chǎn)的每一個(gè)環(huán)節(jié)均符合國際標(biāo)準(zhǔn)。其核心業(yè)務(wù)涵蓋多肽合成（純度范圍從粗品到＞95%）、定制化修飾（如磷酸化、生物素標(biāo)記、環(huán)化、穩(wěn)定同位素標(biāo)記等）以及規(guī)?；a(chǎn)（微克至千克級），并支持小規(guī)模（10-50 nmol）、中等規(guī)模（1-100 mg）及大規(guī)模（＞1 g）的靈活需求。
JPT在肽庫、微陣列及微尺度合成領(lǐng)域擁有技術(shù)，尤其以高通量肽庫開發(fā)見長，可快速生成用于新表位篩選、疫苗設(shè)計(jì)及免疫監(jiān)測的多肽組合。其PepMix™抗原肽池和PepStar™微陣列產(chǎn)品廣泛應(yīng)用于傳染?。ㄈ缧鹿诓《荆?、腫瘤免疫治療及自身免疫疾病的研究，助力科學(xué)家加速靶點(diǎn)驗(yàn)證與臨床轉(zhuǎn)化。此外，公司在新冠疫情期間推出覆蓋SARS-CoV-2全基因組的肽工具包，包含野生型及突變株抗原序列，為全球抗疫提供了關(guān)鍵科研支持。
近年來，JPT持續(xù)擴(kuò)展其抗原肽目錄，新增1001種來自傳染病、腫瘤及代謝性疾病的抗原肽，成為商業(yè)化抗原肽資源庫。通過整合液相色譜-質(zhì)譜聯(lián)用（LC-MS/MS）技術(shù)，公司還提供精準(zhǔn)的蛋白質(zhì)組學(xué)服務(wù)，支持生物標(biāo)志物發(fā)現(xiàn)與定量分析。
JPT的服務(wù)貫穿新療法開發(fā)全周期，從早期靶點(diǎn)識別到臨床級肽制劑生產(chǎn)，滿足細(xì)胞治療、個(gè)性化醫(yī)療及預(yù)防性疫苗的研發(fā)需求。其客戶遍布學(xué)術(shù)界與工業(yè)界，并與多家頂尖機(jī)構(gòu)合作推動(dòng)創(chuàng)新療法的突破。
特別告知：為保證產(chǎn)品質(zhì)量與良好性能，所以在購買相應(yīng)產(chǎn)品的同時(shí)我司會(huì)收取一定量的運(yùn)輸費(fèi)用?。?！本次報(bào)價(jià)有效時(shí)間為2025年5月14日---2025年12月14日。
貨號 | 品名 | 規(guī)格 | 價(jià)格 | 品牌 |
PM-TBEV-CPULTRA | PepMix Tick-borne Encephalitis Virus (Capsid Protein) Ultra | 25ug(approx.15nmol)/peptide | 13566 | jpt |
PM-BKV-VP1 | PepMix BKV (capsid protein VP1) | 25ug(approx.15nmol)/peptide | 9996 | jpt |
PM-BKV-LTA | PepMix BKV (large T antigen) | 25ug(approx.15nmol)/peptide | 11577 | jpt |
SP-MHCI-0088-3 | Antigen Peptide Ovalbumin H-2 Kb (SIIQFEHL) | 10mg(10x1mg) | 8619 | jpt |
SP-CAT-002-1 | Cysteine Peptide | 10mg | 9843 | jpt |
PM-HIV-POL | PepMix HIV-1 (POL) Ultra | 25ug(approx.15nmol)/peptide | 14739 | jpt |
PM-MEASW-HGP | PepMix Measles virus (Hemagglutinin glycoprotein) | 25ug(approx.15nmol)/peptide | 11577 | jpt |
SP-CAT-001-2 | Lysine Peptide | 50mg | 39491 | jpt |
SP-CAT-001-1 | Lysine Peptide | 10mg | 9843 | jpt |
SP-CAT-002-2 | Cysteine Peptide | 50mg | 39491 | jpt |
PM-CEFSX-2 | CEFSX Ultra SuperStim Pool | 15nmol(approx.25ug)/peptide | 14926 | jpt |
PM-LASV-PREGPC | PepMix Lassa virus (Pre-glycoprotein complex) | 25ug(approx.15nmol)/peptide | 10778 | jpt |
PM-NIPAV-GP | PepMix Nipah virus (Glycoprotein G) | 25ug(approx.15nmol)/peptide | 10778 | jpt |
PM-VEEV-E2 | PepMix VEEV (Spike Glycoprotein E2) | 25ug(approx.15nmol)/peptide | 10778 | jpt |
PM-HIV-ENV | PepMix HIV-1 (ENV) Ultra | 25ug(approx.15nmol)/peptide | 14739 | jpt |
PM-CEFT-MHC-II-4 | CEFT MHC-II Pool | 120nmol/peptide | 20893 | jpt |
PM-CEFT-MHC-II-3 | CEFT MHC-II Pool | 15nmol(approx.25ug)/peptide | 3485 | jpt |
PM-HSV2-gC | PepMix HSV2 (gC) | 25ug(approx.15nmol)/peptide | 10778 | jpt |
PM-HSV2-gB | PepMix HSV2 (gB) | 25ug(approx.15nmol)/peptide | 13464 | jpt |
PM-INFA-HADAR21-2 | PepMix Influenza A (HA/H3N2/Darwin/2021) | 25ug(approx.15nmol)/peptide | 10778 | jpt |
PM-INFA-HADAR21-1 | PepMix Influenza A (HA/H3N2/Darwin/2021) | 25ug(approx.15nmol)/peptide | 8636 | jpt |
PM-INFA-HAGUA23 | PepMix Influenza A (HA/H5N1/Guanajuato/2023) | 25ug(approx.15nmol)/peptide | 10778 | jpt |
PM-INFA-NADAR21 | PepMix Influenza A (NA/H3N2/Darwin/2021) | 25ug(approx.15nmol)/peptide | 10778 | jpt |
SP-MHCI-0005-3 | Antigen Peptide CMV pp65 - HLA-A*0201 (NLVPMVATV) | 10mg(10x1mg) | 8619 | jpt |
PM-ERB_ECD | PepMix Human (ErbB2_ECD) | 25ug(approx.15nmol)/peptide | 11577 | jpt |
PM-MAGEA1 | PepMix Human (MAGEA1) | 25ug(approx.15nmol)/peptide | 9996 | jpt |
PM-MM-Survivin | PepMix Mouse (Survivin) | 25ug(approx.15nmol)/peptide | 9265 | jpt |
PM-MUC1 | PepMix Human (Mucin-1) | 25ug(approx.15nmol)/peptide | 10778 | jpt |
PM-CyCMV-UL83 | PepMix CyCMV (TP-UL83) | 25ug(approx.15nmol)/peptide | 10778 | jpt |
PM-ACTS | PepMix Human (Actin) | 25ug(approx.15nmol)/peptide | 8789 | jpt |
PM-Pan-PERTselect | PepMix Pan-Pertussis Select Pool | 15nmol(approx.25ug)/peptide | 13566 | jpt |
PM-TARP | PepMix Human (TCRgamma alternate reading frame protein TARP) | 25ug(approx.15nmol)/peptide | 9265 | jpt |
PM-CEA | PepMix Human (CEA) | 25ug(approx.15nmol)/peptide | 11577 | jpt |
PM-HSV2-E3 | PepMix HSV2 (E3 ICP0) | 25ug(approx.15nmol)/peptide | 12512 | jpt |
SP-MHCI-0160-2 | Antigen Peptide HRSV M - H-2 Db (NAITNAKII) | 1mg | 2873 | jpt |
SP-MHCI-0001-2 | Antigen Peptide NY-ESO-1 - HLA-A*0201 (SLLMWITQC) | 1mg | 2873 | jpt |
PM-HPV16-E2 | PepMix HPV16 (E2) | 25ug(approx.15nmol)/peptide | 9996 | jpt |
PM-INFB-NAAUT21 | PepMix Influenza B (NA/H0N0/Austria/2021) | 25ug(approx.15nmol)/peptide | 10778 | jpt |
PM-INFB-HAPHU13-1 | PepMix Influenza B (HA/H0N0/Phuket/2013) | 25ug(approx.15nmol)/peptide | 8636 | jpt |
PM-INFB-HAAUT21-1 | PepMix Influenza B (HA/H0N0/Austria/2021) | 25ug(approx.15nmol)/peptide | 8636 | jpt |
PM-Pan-PXVselect-1 | PepMix Pan-Poxviridae Select | 15nmol(approx.25ug)/peptide | 11764 | jpt |
PM-Pan-HHV6select-1 | PepMix Pan-HHV6 Select | 15nmol(approx.25ug)/peptide | 12546 | jpt |
PM-VZV-gEO | PepMix VZV (gE/Oka) | 25ug(approx.15nmol)/peptide | 11118 | jpt |
PM-Pan-SARS2select01-1 | PepMix Pan-SARS-CoV-2 Select | 15nmol(approx.25ug)/peptide | 11764 | jpt |
PM-ASPFU-CRF1 | PepMix Aspergillus fumigatus (Probable glycosidase crf1) | 25ug(approx.15nmol)/peptide | 9996 | jpt |
PM-HIV-NEF | PepMix HIV-1 (NEF) Ultra | 25ug(approx.15nmol)/peptide | 14739 | jpt |
PM-HIV-GAG | PepMix HIV-1 (GAG) Ultra | 25ug(approx.15nmol)/peptide | 14739 | jpt |
SP-MHCI-0004-2 | Influenza A MP (58-66) Peptide (GILGFVFTL) | 1mg | 2873 | jpt |
PM-MAGEA3 | PepMix Human (MAGEA3) | 25ug(approx.15nmol)/peptide | 9996 | jpt |
PM-MAGEC1 | PepMix Human (MAGEC1) | 25ug(approx.15nmol)/peptide | 13464 | jpt |
PM-KKLC1 | PepMix Human (KKLC1) | 25ug(approx.15nmol)/peptide | 9265 | jpt |
PM-CLD6 | PepMix Human (Claudin-6) | 25ug(approx.15nmol)/peptide | 9996 | jpt |
PM-INFA-HAIndo | PepMix Influenza A (HA/Indonesia (H5N1)) | 25ug(approx.15nmol)/peptide | 10778 | jpt |
RT-0019-2 | PepStar Human CMV (IE-1) | 1microarray(1"x3") | 15266 | jpt |
PM-INFA_NA | PepMix Influenza A (NA/California (H1N1) | 25ug(approx.15nmol)/peptide | 10778 | jpt |
PM-C-SARS2-WSP-2 | PepMix Collection SARS-CoV-2 Wuhan Structural Proteins | 25ug(approx.15nmol)/peptide | 62339 | jpt |
PM-Pan-RSVselect-1 | PepMix Pan-RSV Select | 15nmol(approx.25ug)/peptide | 13566 | jpt |
PM-TPTE | PepMix Human (TPTE) | 25ug(approx.15nmol)/peptide | 10778 | jpt |
PM-Tyr | PepMix Human (Tyrosinase) | 25ug(approx.15nmol)/peptide | 10778 | jpt |
PM-HPV16-E1 | PepMix HPV16 (E1) | 25ug(approx.15nmol)/peptide | 11577 | jpt |
PM-EBV-GP350/GP340 | PepMix EBV (GP350/GP340) | 25ug(approx.15nmol)/peptide | 14518 | jpt |
PM-PD-L1 | PepMix Human (PD-L1) | 25ug(approx.15nmol)/peptide | 9996 | jpt |
PM-CyCMV-UL55 | PepMix CyCMV (GP-UL55) | 25ug(approx.15nmol)/peptide | 12512 | jpt |
PM-CEFT-1 | CEFT Pool | 15nmol(approx.25ug)/peptide | 3247 | jpt |
RT-EBV-LMP1-1 | PepStar EBV (LMP1) | 1microarray(1"x3") | 2431 | jpt |
PM-CEF-S-1 | CEF Pool (standard) | 15nmol(approx.25ug)/peptide | 3247 | jpt |
PM-NYE | PepMix Human (NY-ESO-1) | 25ug(approx.15nmol)/peptide | 8789 | jpt |
PM-WT1 | PepMix Human (WT1/WT33) | 25ug(approx.15nmol)/peptide | 9775 | jpt |
PM-MAGEA4 | PepMix Human (MAGEA4) | 25ug(approx.15nmol)/peptide | 9996 | jpt |
PM-OIP4 | PepMix Human (Prame/OIP4) | 25ug(approx.15nmol)/peptide | 9775 | jpt |
PM-SSX2 | PepMix Human (SSX2) | 25ug(approx.15nmol)/peptide | 9265 | jpt |
PM-Survivin | PepMix Human (Survivin) | 25ug(approx.15nmol)/peptide | 9265 | jpt |
PM-MYCTU-AG85B | PepMix M. tuberculosis (Ag85B) | 25ug(approx.15nmol)/peptide | 9996 | jpt |
PM-MYCTU-MPT64 | PepMix M. tuberculosis (MPT64) | 25ug(approx.15nmol)/peptide | 9996 | jpt |
PM-MYCTU-AG85A | PepMix M. tuberculosis (Ag85A) | 25ug(approx.15nmol)/peptide | 9996 | jpt |
PM-CEFX-3 | CEFX Ultra SuperStim Pool MHC-II Subset | 15nmol(approx.25ug)/peptide | 4420 | jpt |
PM-HSV2-gD | PepMix HSV2 (gD) | 25ug(approx.15nmol)/peptide | 9996 | jpt |
PM-MYCTU-ESAT6 | PepMix M. tuberculosis (ESAT-6) | 25ug(approx.15nmol)/peptide | 9265 | jpt |
PM-MYCTU-TB104 | PepMix M. tuberculosis (TB10.4) | 25ug(approx.15nmol)/peptide | 9265 | jpt |
PM-MYCTU-CFP10 | PepMix M. tuberculosis (CFP-10) | 25ug(approx.15nmol)/peptide | 9265 | jpt |
PM-PSA | PepMix Human (Prostate-specific antigen PSA) | 25ug(approx.15nmol)/peptide | 9996 | jpt |
PM-RABVH-GP | PepMix Rabies virus (Glycoprotein) | 25ug(approx.15nmol)/peptide | 10778 | jpt |
PM-AAV9-VP1 | PepMix AAV9 (Capsid Protein VP1) | 25ug(approx.15nmol)/peptide | 11577 | jpt |
PM-SARS2-SMUT15-1 | PepMix SARS-CoV-2 (Spike XBB.1.5) | 25ug(approx.15nmol)/peptide | 17901 | jpt |
SP-Ab-24_0.1 | S26C-Beta-Amyloid (1-40) Dimer HFIP treated | 0.1mg | 5814 | jpt |
AT-MA_01 | Acetylome - Deacetylase Microarray | 1microarray(3subarraysperslide) | 12869 | jpt |
AT-MA_02 | Acetylome - Acetyltransferase Microarray | 1microarray(3subarraysperslide) | 12869 | jpt |
CAMCheck-1000pm | CAMCheck Kit | 1000pmol/peptide | 12461 | jpt |
CAMCheck-10pm | CAMCheck Kit | 10pmol/peptide | 2924 | jpt |
EMPS-229E-S-1 | Epitope Mapping Peptide Set (EMPS) HCoV-229E (Spike Glycoprotein) | 5ug/peptideasindividualpeptideandinmatrixpools | 96492 | jpt |
EMPS-CVHSA-S-1 | Epitope Mapping Peptide Set (EMPS) SARS-CoV (Spike Glycoprotein) | 5ug/peptideasindividualpeptideandinmatrixpools | 96492 | jpt |
EMPS-HKU1-S-1 | Epitope Mapping Peptide Set (EMPS) HCoV-HKU1 (Spike Glycoprotein) | 5ug/peptideasindividualpeptideandinmatrixpools | 96492 | jpt |
EMPS-MERS-CoV-S-1 | Epitope Mapping Peptide Set (EMPS) MERS-CoV (Spike Glycoprotein) | 5ug/peptideasindividualpeptideandinmatrixpools | 96492 | jpt |
EMPS-NL63-S-1 | Epitope Mapping Peptide Set (EMPS) HCoV-NL63 (Spike Glycoprotein) | 5ug/peptideasindividualpeptideandinmatrixpools | 96492 | jpt |
EMPS-OC43-S-1 | Epitope Mapping Peptide Set (EMPS) HCoV-OC43 (Spike Glycoprotein) | 5ug/peptideasindividualpeptideandinmatrixpools | 96492 | jpt |
EMPS-WCPV-NCAP-1 | Epitope Mapping Peptide Set (EMPS) SARS-CoV-2 (NCAP) | 5ug/peptideasindividualpeptideandinmatrixpools | 65705 | jpt |
EMPS-WCPV-S-1 | Epitope Mapping Peptide Set (EMPS) SARS-CoV-2 (Spike Glycoprotein) | 5ug/peptideasindividualpeptideandinmatrixpools | 96492 | jpt |
EMPS-WCPV-VEMP-1 | Epitope Mapping Peptide Set (EMPS) SARS-CoV-2 (VEMP) | 5ug/peptideasindividualpeptideandinmatrixpools | 15708 | jpt |
EMPS-WCPV-VME-1 | Epitope Mapping Peptide Set (EMPS) SARS-CoV-2 (VME1) | 5ug/peptideasindividualpeptideandinmatrixpools | 39491 | jpt |
His_MA_01 | Histone Code Peptide Microarrays | 1microarray(3subarraysperslide) | 11611 | jpt |
MA-24-4c | ArraySlide 24-4 chamber | ea | 15453 | jpt |
PM-229E-NCAP-1 | PepMix HCoV-229E (NCAP) | 25ug(approx.15nmol)/peptide | 8517 | jpt |
PM-229E-S-1 | PepMix HCoV-229E (Spike Glycoprotein) | 25ug(approx.15nmol)/peptide | 17901 | jpt |
PM-229E-S-2 | PepMix HCoV-229E (Spike Glycoprotein) | 25ug(approx.15nmol)/peptide | 25058 | jpt |
（*此為部分產(chǎn)品價(jià)格,完整價(jià)格請下載文件）
